Abstract
Cancer is a group of diseases characterized by uncontrolled growth and spread
of abnormal cells. If the spread is not controlled, it can result in death.
Cancer is caused by both external (chemicals, radiation and viruses) and
internal (hormones, immune conditions and inherited mutations) factors. Causal
factors may act together or in sequence to initiate or promote carcinogenesis.
Ten or more years often pass between exposures or mutations and detectable
cancer. Cancer is treated by surgery, radiation, chemotherapy, hormones and
immunotherapy. The purpose of this TriMark Publications report is to describe
the specific segment of the diagnostic market aimed at analysis cytology (the
examination of cells using optical microscopy methods) specimens derived from
the human female reproductive tract. It examines the measurement devices and
their reagents and supplies used in hospitals, clinics, commercial
laboratories and research institutions to detect cells and proteins for the
diagnosis and monitoring of disease. The study describes the analytical
methods used to separate, isolate, characterize and quantitate cells, DNA and
proteins complex in biological systems related to the diagnosis and treatment
of disease of the female reproductive tract, such as the cervix and vagina.
The emphasis is on those companies and products that are actively developing
and marketing laboratory instrumentation, reagents and supplies for performing
cytology and related molecular diagnostic tests, such as human papillomavirus
(HPV) and other inflammatory and sexually-transmitted diseases.